UTP [Ligand Id: 1734] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL336296 (INS-316, INS316, Uridine 5'-triphosphate, Uridine-5'-triphosphate, Uridine triphosphate, UTP) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| P2Y1 receptor/Purinergic receptor P2Y1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4315] [GtoPdb: 323] [UniProtKB: P47900] | ||||||||
| ChEMBL | Evaluated for agonist activity against phospholipase C coupled P2Y purinoceptor 1 (P2Y1) of human erythrocytes | F | 4 | pEC50 | >100000 | nM | EC50 | J Med Chem (2002) 45: 4057-4093 [PMID:12213051] |
| ChEMBL | Agonist activity at human cloned P2Y1 receptor expressed in human 1321N1 by FLIPR assay | F | 5.7 | pEC50 | >2000 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 562-565 [PMID:17011188] |
| ChEMBL | Agonist activity at human cloned P2Y1 receptor expressed in human 1321N1 by FLIPR assay | F | 5.7 | pEC50 | >2000 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 558-561 [PMID:17079144] |
| P2Y11 receptor/Purinergic receptor P2Y11 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4867] [GtoPdb: 327] [UniProtKB: Q96G91] | ||||||||
| ChEMBL | Agonist activity against phospholipase C coupled human P2Y purinoceptor 11 (P2Y11) | F | 4 | pEC50 | >100000 | nM | EC50 | J Med Chem (2002) 45: 4057-4093 [PMID:12213051] |
| GtoPdb | - | - | 5.2 | pEC50 | - | - | - | Mol Pharmacol (2003) 63: 1356-63 [PMID:12761346] |
| P2Y2 receptor/Purinergic receptor P2Y2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4398] [GtoPdb: 324] [UniProtKB: P41231] | ||||||||
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R272A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 4.69 | pEC50 | 20600 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor C278S mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 5.68 | pEC50 | 2090 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Agonist activity at P2Y2 receptor in NG108-15 cells (unknown origin) | F | 5.9 | pEC50 | 1250 | nM | EC50 | Bioorg Med Chem (2018) 26: 366-375 [PMID:29254895] |
| ChEMBL | Agonist activity at P2Y2 receptor H184A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay | F | 6 | pEC50 | 996 | nM | EC50 | J Med Chem (2017) 60: 8425-8440 [PMID:28938069] |
| ChEMBL | Agonist activity at P2Y2 receptor Y288F mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay | F | 6.04 | pEC50 | 911 | nM | EC50 | J Med Chem (2017) 60: 8425-8440 [PMID:28938069] |
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged wild type 1 human P2Y2 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 6.11 | pEC50 | 781 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium concentration by dual-excitation spectrofluorimetric analysis | F | 6.19 | pEC50 | 640 | nM | EC50 | Eur J Med Chem (2009) 44: 1525-1536 [PMID:18760862] |
| ChEMBL | Agonist activity at human P2Y purinoceptor 2 expressed in human 1321N1 cells assessed as increase in intracellular calcium concentration by spectrofluorimetry | F | 6.19 | pEC50 | 640 | nM | EC50 | J Med Chem (2012) 55: 437-448 [PMID:22107038] |
| ChEMBL | Activity against human P2Y2-GFP expressed in A549 cells by intracellular calcium increase | F | 6.35 | pEC50 | 450 | nM | EC50 | J Med Chem (2006) 49: 1980-1990 [PMID:16539385] |
| ChEMBL | Agonist activity at P2Y2 receptor in BEA cells (unknown origin) | F | 6.8 | pEC50 | 160 | nM | EC50 | Bioorg Med Chem (2018) 26: 366-375 [PMID:29254895] |
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor Y118A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 6.8 | pEC50 | 157 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Evaluated for agonist activity against phospholipase C coupled recombinant human P2Y purinoceptor 2 (P2Y2) | F | 6.85 | pEC50 | 140 | nM | EC50 | J Med Chem (2002) 45: 4057-4093 [PMID:12213051] |
| ChEMBL | Agonist activity at human GFP-tagged P2Y2 receptor expressed in human 1321N1 cells assessed as intracellular calcium mobilization by fura2/AM-based fluorescence spectrophotometry | F | 6.85 | pEC50 | 140 | nM | EC50 | Bioorg Med Chem (2012) 20: 5483-5495 [PMID:22901672] |
| ChEMBL | Agonist activity at P2Y2 receptor (unknown origin) assessed as reduction in inositol phosphate accumulation | F | 6.85 | pEC50 | 140 | nM | EC50 | Bioorg Med Chem (2018) 26: 366-375 [PMID:29254895] |
| ChEMBL | Agonist activity at human P2Y2 transfected in human 1321N1 cells | B | 6.85 | pEC50 | 140 | nM | EC50 | J Med Chem (2016) 59: 9981-10005 [PMID:27413802] |
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R180A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 6.86 | pEC50 | 138 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R177A_R180A double mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 6.91 | pEC50 | 124 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R194H mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 6.92 | pEC50 | 121 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Agonist activity at human P2Y2 receptor expressed in 1321N1 cells assessed as [3H]-inositol phosphate accumulation measured after 90 mins by anion exchange chromatographic method | F | 6.92 | pEC50 | 120 | nM | EC50 | Bioorg Med Chem (2018) 26: 366-375 [PMID:29254895] |
| ChEMBL | Agonist activity at P2Y2 receptor expressed in 1321N1 cells assessed as cytosolic calcium level | F | 6.96 | pEC50 | 109.65 | nM | EC50 | J Med Chem (2007) 50: 5600-5607 [PMID:17941622] |
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor Y198A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 6.97 | pEC50 | 108 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells assessed as calcium elevation by fura2/AM assay | F | 7 | pEC50 | 100 | nM | EC50 | J Med Chem (2010) 53: 1673-1685 [PMID:20095577] |
| ChEMBL | Agonist activity at P2Y2 receptor in human CF/T43 cells | F | 7 | pEC50 | 100 | nM | EC50 | Bioorg Med Chem (2018) 26: 366-375 [PMID:29254895] |
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged wild type 3 human P2Y2 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 7.09 | pEC50 | 80.4 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Agonist activity at P2Y2 receptor S193A mutant (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay | F | 7.15 | pEC50 | 70.6 | nM | EC50 | J Med Chem (2017) 60: 8425-8440 [PMID:28938069] |
| ChEMBL | Agonist activity at human P2Y2 | F | 7.22 | pEC50 | 60 | nM | EC50 | J Med Chem (2011) 54: 4018-4033 [PMID:21528910] |
| ChEMBL | Agonist activity at human recombinant P2Y2 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production by scintillation proximity assay | F | 7.22 | pEC50 | 60 | nM | EC50 | J Med Chem (2010) 53: 4488-4501 [PMID:20446735] |
| ChEMBL | Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate accumulation by scintillation proximity assay | F | 7.22 | pEC50 | 60 | nM | EC50 | Bioorg Med Chem (2008) 16: 6319-6332 [PMID:18514530] |
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged wild type 4 human P2Y2 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 7.23 | pEC50 | 59 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Agonist activity at human recombinant P2Y2 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production after 30 mins by scintillation proximity assay | F | 7.26 | pEC50 | 55 | nM | EC50 | J Med Chem (2011) 54: 4018-4033 [PMID:21528910] |
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor R177A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 7.3 | pEC50 | 50.1 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Agonist activity at human recombinant P2Y2 receptor expressed in 1321N1 cells assessed as stimulation of phospholipase C | F | 7.31 | pEC50 | 49 | nM | EC50 | J Med Chem (2007) 50: 1166-1176 [PMID:17302398] |
| ChEMBL | Agonist activity at human P2Y2 receptor expressed in 1321N1 cells assessed as IP accumulation by SPA | F | 7.37 | pEC50 | 43 | nM | EC50 | J Med Chem (2006) 49: 7076-7087 [PMID:17125260] |
| ChEMBL | Agonist activity at N-terminal HA epitope-tagged human P2Y2 receptor Y114A mutant expressed in human 1321N1 cells assessed as increase in intracellular calcium level | F | 7.43 | pEC50 | 37.2 | nM | EC50 | J Med Chem (2009) 52: 2762-2775 [PMID:19419204] |
| ChEMBL | Agonist activity evaluated as change in the level of cytosolic calcium in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y2 receptor | F | 7.52 | pEC50 | 30 | nM | EC50 | Bioorg Med Chem Lett (2001) 11: 157-160 [PMID:11206448] |
| ChEMBL | Agonist activity at human P2Y2 receptor expressed in human 1321N1 cells assessed as stimulation of PLC-induced [3H]inositol phosphate production after 30 mins by scintillation counting | F | 7.7 | pEC50 | 20 | nM | EC50 | Bioorg Med Chem (2012) 20: 2304-2315 [PMID:22386981] |
| ChEMBL | Agonist activity at human recombinant P2Y2 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate intracellular accumulation by scintillation proximity assay | F | 7.75 | pEC50 | 17.9 | nM | EC50 | J Med Chem (2011) 54: 2878-2890 [PMID:21417463] |
| GtoPdb | - | - | 8.1 | pEC50 | - | - | - |
Br J Pharmacol (1995) 116: 1619-27 [PMID:8564228]; J Med Chem (2002) 45: 208-18 [PMID:11754592] |
| ChEMBL | Agonist activity at human P2Y2 receptor expressed in human 1321N1 by FLIPR assay | F | 8.15 | pEC50 | 7 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 558-561 [PMID:17079144] |
| ChEMBL | Agonist activity at human P2Y2 receptor expressed in human 1321N1 by FLIPR assay | F | 8.15 | pEC50 | 7 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 562-565 [PMID:17011188] |
| ChEMBL | Agonist activity at wild type P2Y2 receptor (unknown origin) expressed in human 1321N1 astrocytoma cells assessed as increase in intracellular calcium mobilization after 1 hr by Fluo-4 AM dye based fluorescence assay | F | 8.25 | pEC50 | 5.61 | nM | EC50 | J Med Chem (2017) 60: 8425-8440 [PMID:28938069] |
| P2Y2 receptor/Purinergic receptor P2Y2 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075298] [GtoPdb: 324] [UniProtKB: P35383] | ||||||||
| ChEMBL | Antagonist activity at mouse P2Y2 receptor expressed in NG108-15 hybrid cells assessed as inhibition of 1 uM UTP-induced intracellular calcium release preincubated 30 mins before UTP challenge by fluorescence assay | F | 5.82 | pIC50 | 1510 | nM | IC50 | Bioorg Med Chem (2009) 17: 5071-5079 [PMID:19523835] |
| ChEMBL | Agonist activity at mouse P2Y2 receptor expressed in NG108-15 hybrid cells assessed as increase in intracellular calcium release by fluorescence assay | F | 5.9 | pEC50 | 1260 | nM | EC50 | Bioorg Med Chem (2009) 17: 5071-5079 [PMID:19523835] |
| P2Y2 receptor/Purinergic receptor P2Y2 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4419] [GtoPdb: 324] [UniProtKB: P41232] | ||||||||
| ChEMBL | Activity against rat P2Y2-GFP transfected in HEK293 cells by intracellular calcium increase | F | 6.89 | pEC50 | 130 | nM | EC50 | J Med Chem (2006) 49: 1980-1990 [PMID:16539385] |
| P2Y4 receptor/Pyrimidinergic receptor P2Y4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2123] [GtoPdb: 325] [UniProtKB: P51582] | ||||||||
| ChEMBL | The compound was evaluated for antagonist activity against phospholipase C coupled recombinant human P2Y purinoceptor 4 (P2Y4) | F | 5.6 | pEC50 | 2500 | nM | EC50 | J Med Chem (2002) 45: 4057-4093 [PMID:12213051] |
| ChEMBL | Agonist activity at human GFP-tagged P2Y4 receptor expressed in human 1321N1 cells assessed as intracellular calcium mobilization by fura2/AM-based fluorescence spectrophotometry | F | 6.05 | pEC50 | 900 | nM | EC50 | Bioorg Med Chem (2012) 20: 5483-5495 [PMID:22901672] |
| ChEMBL | Agonist activity at human P2Y4 transfected in human 1321N1 cells | B | 6.26 | pEC50 | 550 | nM | EC50 | J Med Chem (2016) 59: 9981-10005 [PMID:27413802] |
| GtoPdb | - | - | 6.3 | pEC50 | - | - | - | Mol Pharmacol (2000) 57: 926-31 [PMID:10779375] |
| ChEMBL | Agonist activity at human P2Y4 receptor expressed in human 1321N1 cells assessed as calcium elevation by fura2/AM assay | F | 6.3 | pEC50 | 500 | nM | EC50 | J Med Chem (2010) 53: 1673-1685 [PMID:20095577] |
| ChEMBL | Agonist activity at human P2Y purinoceptor 4 expressed in human 1321N1 cells assessed as increase in intracellular calcium concentration by spectrofluorimetry | F | 6.32 | pEC50 | 480 | nM | EC50 | J Med Chem (2012) 55: 437-448 [PMID:22107038] |
| ChEMBL | Agonist activity at human P2Y4 receptor expressed in human 1321N1 cells assessed as increase in intracellular calcium concentration by dual-excitation spectrofluorimetric analysis | F | 6.32 | pEC50 | 480 | nM | EC50 | Eur J Med Chem (2009) 44: 1525-1536 [PMID:18760862] |
| ChEMBL | Agonist activity evaluated as change in the level of cytosolic calcium in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y4 receptor | F | 7 | pEC50 | 100 | nM | EC50 | Bioorg Med Chem Lett (2001) 11: 157-160 [PMID:11206448] |
| ChEMBL | Agonist activity at human recombinant P2Y4 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production by scintillation proximity assay | F | 7.05 | pEC50 | 90 | nM | EC50 | J Med Chem (2010) 53: 4488-4501 [PMID:20446735] |
| ChEMBL | Agonist activity at human P2Y4 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate accumulation by scintillation proximity assay | F | 7.05 | pEC50 | 90 | nM | EC50 | Bioorg Med Chem (2008) 16: 6319-6332 [PMID:18514530] |
| ChEMBL | Agonist activity at human P2Y4 | F | 7.05 | pEC50 | 90 | nM | EC50 | J Med Chem (2011) 54: 4018-4033 [PMID:21528910] |
| ChEMBL | Agonist activity at human recombinant P2Y4 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate intracellular accumulation by scintillation proximity assay | F | 7.05 | pEC50 | 88.4 | nM | EC50 | J Med Chem (2011) 54: 2878-2890 [PMID:21417463] |
| ChEMBL | Agonist activity at human P2Y4 receptor expressed in 1321N1 cells assessed as IP accumulation by SPA | F | 7.06 | pEC50 | 87 | nM | EC50 | J Med Chem (2006) 49: 7076-7087 [PMID:17125260] |
| ChEMBL | Agonist activity at human recombinant P2Y4 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production after 30 mins by scintillation proximity assay | F | 7.1 | pEC50 | 80 | nM | EC50 | J Med Chem (2011) 54: 4018-4033 [PMID:21528910] |
| ChEMBL | Agonist activity at human recombinant P2Y4 receptor expressed in 1321N1 cells assessed as stimulation of phospholipase C | F | 7.14 | pEC50 | 73 | nM | EC50 | J Med Chem (2007) 50: 1166-1176 [PMID:17302398] |
| ChEMBL | Agonist activity at human cloned P2Y4 receptor expressed in human 1321N1 by FLIPR assay | F | 7.41 | pEC50 | 39 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 562-565 [PMID:17011188] |
| ChEMBL | Agonist activity at human cloned P2Y4 receptor expressed in human 1321N1 by FLIPR assay | F | 7.41 | pEC50 | 39 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 558-561 [PMID:17079144] |
| P2Y4 receptor/Pyrimidinergic receptor P2Y4 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2124] [GtoPdb: 325] [UniProtKB: O35811] | ||||||||
| ChEMBL | The compound was evaluated for antagonist activity against phospholipase C coupled recombinant rat P2Y purinoceptor 4 (P2Y4) | F | 5.59 | pEC50 | 2600 | nM | EC50 | J Med Chem (2002) 45: 4057-4093 [PMID:12213051] |
| GtoPdb | - | - | 5.6 | pEC50 | - | - | - | Br J Pharmacol (1998) 124: 428-30 [PMID:9647463] |
| P2Y6 receptor/Pyrimidinergic receptor P2Y6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4714] [GtoPdb: 326] [UniProtKB: Q15077] | ||||||||
| ChEMBL | Agonist activity at human recombinant P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production after 30 mins by scintillation proximity assay | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2011) 54: 4018-4033 [PMID:21528910] |
| ChEMBL | Agonist activity evaluated as change in the level of cytosolic calcium in 1321N astrocytoma cells infected with a retrovirus encoding the human P2Y6 receptor | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem Lett (2001) 11: 157-160 [PMID:11206448] |
| ChEMBL | Agonist activity at human recombinant P2Y6 receptor expressed in 1321N1 cells assessed as intracellular calcium mobilization | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2007) 50: 1166-1176 [PMID:17302398] |
| ChEMBL | Agonist activity at human P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate accumulation by scintillation proximity assay | F | 5 | pEC50 | >10000 | nM | EC50 | Bioorg Med Chem (2008) 16: 6319-6332 [PMID:18514530] |
| ChEMBL | Agonist activity at human recombinant P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate production by scintillation proximity assay | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2010) 53: 4488-4501 [PMID:20446735] |
| GtoPdb | - | - | 5.2 | pEC50 | - | - | - | Biochem Biophys Res Commun (1996) 222: 303-8 [PMID:8670200] |
| ChEMBL | The compound was evaluated for agonist activity against phospholipase C coupled recombinant human P2Y purinoceptor 6 (P2Y6) | F | 5.22 | pEC50 | 6000 | nM | EC50 | J Med Chem (2002) 45: 4057-4093 [PMID:12213051] |
| ChEMBL | Agonist activity at human recombinant P2Y6 receptor expressed in human 1321N1 cells assessed as [3H]inositol phosphate intracellular accumulation by scintillation proximity assay | F | 5.22 | pEC50 | 6000 | nM | EC50 | J Med Chem (2011) 54: 2878-2890 [PMID:21417463] |
| ChEMBL | Agonist activity at human cloned P2Y6 receptor expressed in human 1321N1 by FLIPR assay | F | 6.37 | pEC50 | 424 | nM | EC50 | Bioorg Med Chem Lett (2007) 17: 562-565 [PMID:17011188] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
